Explore more publications!

Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

Press releases published on April 21, 2026

TripleTen Launches New AI Product Management Program for Professionals Needing AI Skills
Associate Owners Group Acquires Your IA, Expanding AOG’s Footprint in the Registered Investment Advisory Space
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
Airia Shortlisted in The 2026 Security Awards
AcuityTec Expands Device and Payment Intelligence to Strengthen Fraud Detection Across the Customer Lifecycle
QuestionPro Acquires Fathom to Lead in AI-Powered Open-Ended Analysis
Posifa Technologies Introduces PGS5100 Series Hydrogen Sensors for EV Battery Safety and Leak Monitoring
Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching
Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
The Ungoverned Workforce: Cybersecurity Insiders Finds 92% Lack Visibility Into AI Identities
DocHub Expands PDF Editing Capabilities With The New Edit Text Feature
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions